Sort
21,281 grants matching “influenza”
Mechanisms of broadly neutralizing humoral immunity against influenza viruses
$1,918,351Peter Palese · Icahn School Of Medicine At Mount Sinai · U19 · FY2018 · AI
Mechanisms of broadly neutralizing humoral immunity against influenza viruses
$1,918,351Peter Palese · Icahn School Of Medicine At Mount Sinai · U19 · FY2015 · AI
Mechanisms of broadly neutralizing humoral immunity against influenza viruses
$1,918,351Peter Palese · Icahn School Of Medicine At Mount Sinai · U19 · FY2017 · AI
Mechanisms of broadly neutralizing humoral immunity against influenza viruses
$1,918,351Peter Palese · Icahn School Of Medicine At Mount Sinai · U19 · FY2016 · AI
COVID-FIS: A PHASE 2 PLACEBO-CONTROLLED PILOT STUDY IN COVID-19 OF FISETIN TO ALLEVIATE DYSFUNCTION AND EXCESSIVE INFLAMMATORY RESPONSE IN OLDER ADULTS IN NURSING HOMES
$1,917,854James L. Kirkland · Mayo Clinic Rochester · R01 · FY2020 · AG
B Cell Biology
$1,916,883Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses
$1,916,770Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
AGREEMENT ORDER FA8650-10-2-6EO1 IS HEREBY ESTABLISHED FOR THE "LABORATORY-BASED DOD GLOBAL INFLUENZA " EFFORT.
$1,915,294The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. · · FY2010 · Department of the Air Force
Adjuvant Discovery for Vaccines against Influenza Virus
$1,914,549Ofer Levy · Boston Children'S Hospital · N01 · FY2016 · AI
Live attenuated vaccines for epidemic and pandemic flu
$1,914,536Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U01 · FY2009 · AI
NIAID Centers of Excellence for Influenza Research and Response
$1,913,874Anice Lowen · Emory University · N01 · FY2024 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$1,911,580Walter A. Orens · Emory University · N01 · FY2020 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$1,909,929John Jay Treanor · University Of Rochester · N01 · FY2017 · AI
Population Based Epidemiological Studies on Influenza/Other Respiratory Pathogens
$1,909,777Darrell Singer · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2009 · IP
RESPIRATORY PATHOGENS RESEARCH CENTERS (RPRC)
$1,906,135David Topham · University Of Rochester · N01 · FY2018 · AI
ADJUVANT COMPARISON AND CHARACTERIZATION
$1,906,004Philip Felgner · University Of California-Irvine · N01 · FY2023 · AI
High-throughput screening for novel adjuvant discovery for vaccines against influenza virus
$1,904,860Nikolai Petrovsky · Vaxine Pty Ltd · N01 · FY2018 · AI
Disordered Proteostasis as a Driver of Disease in the Aging Lung
$1,904,520Gr Scott Budinger · Northwestern University At Chicago · P01 · FY2024 · AG
Immune Function and Biodefense in Children, Elderly, and the Immunocrompromised
$1,903,547Jack Gorski · Versiti Wisconsin, Inc. · N01 · FY2010 · AI
Adjuvant Discovery for Vaccines against West Nile Virus and Influenza
$1,901,545Dennis Carson · University Of California, San Diego · N01 · FY2018 · AI
Preclinical Studies of Vaccines for Pandemic Influenza
$1,901,482Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Innovative Influenza Therapeutic and Prophylactic for Biodefense Applications
$1,900,794Jane Ryan · Biota Scientific Management · U01 · FY2007 · AI
Modeling affinity maturation at molecular resolution
$1,900,400Thomas B Kepler · Boston University Medical Campus · U19 · FY2019 · AI
The Infectious Diseases Clinical Research Program (IDCRP)
$1,900,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2013 · AI
Infectious Disease Clinical Research Program
$1,900,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2011 · AI